| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |